NewGenIvf Group Ltd (NIVF): Operating Cash Flow

Annual figures by period end, from SEC filings.

-$10.93M
Year ended 2025-12-31
$1.71M2021-12-31: $1.43M2022-12-31: $1.71M2023-12-31: -$1.77M2024-12-31: -$8.26M2025-12-31: -$10.93M-$10.93M
2021-12-31 Operating Cash Flow (USD) 2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31-$10.93Mn/m2026-03-31, From 2025-01-01
2024-12-31-$8.26Mn/m2026-03-31, From 2024-01-01
2023-12-31-$1.77Mn/m2026-03-31, From 2023-01-01
2022-12-31$1.71M+19.4%2025-05-15, From 2022-01-01
2021-12-31$1.43Mn/a2024-08-20, From 2021-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Services-Misc Health & Allied Services, NEC), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
NewGenIvf Group Ltd (NIVF)2025-12-31-$10.93Mn/m
Cryo Cell International Inc (CCEL)2025-11-30$5.48M-8.9%
Mangoceuticals, Inc. (MGRX)2025-12-31-$5.85Mn/m
Pacific Health Care Organization Inc (PFHO)2025-12-31$1.16M+71.9%
Marpai, Inc. (MRAI)2025-12-31-$7.45Mn/m
Charming Medical Ltd (MCTA)2026-03-31-$1.22Mn/m
Viemed Healthcare, Inc. (VMD)2025-12-31$51.92M+32.8%
BioRestorative Therapies, Inc. (BRTX)2025-12-31-$10.79Mn/m
Progyny, Inc. (PGNY)2025-12-31$210.19M+17.4%

Compare NIVF, CCEL, MGRX, PFHO side by side · Screen every company in Services-Misc Health & Allied Services, NEC ↗